# Pietro Ravani

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/pietro-ravani/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,253 |
| Field | Dialysis and Renal Disease Management |
| h-index | 73 |
| i10-index | 201 |
| Last Known Institution | University of Calgary |
| OpenAlex ID | https://openalex.org/A5090372922 |
| ORCID iD | https://orcid.org/0000-0001-6973-8570 |
| Works | 351 |

## Researcher papers

- [Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens](https://scholariq.org/papers/discovery-of-new-risk-loci-for-iga-nephropathy-implicates-genes-involved-in/)
- [Genome-wide association study identifies susceptibility loci for IgA nephropathy](https://scholariq.org/papers/genome-wide-association-study-identifies-susceptibility-loci-for-iga-nephropathy/)
- [Associations Between Acute Kidney Injury and Cardiovascular and Renal Outcomes After Coronary Angiography](https://scholariq.org/papers/associations-between-acute-kidney-injury-and-cardiovascular-and-renal-outcomes/)
- [The 2014 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension](https://scholariq.org/papers/the-2014-canadian-hypertension-education-program-recommendations-for-blood/)
- [Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial](https://scholariq.org/papers/rituximab-or-cyclophosphamide-in-the-treatment-of-membranous-nephropathy-the-ri/)
- [Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry](https://scholariq.org/papers/renal-replacement-therapy-for-autosomal-dominant-polycystic-kidney-disease-adpkd/)
- [Timing and Outcome of Renal Replacement Therapy in Patients with Congenital Malformations of the Kidney and Urinary Tract](https://scholariq.org/papers/timing-and-outcome-of-renal-replacement-therapy-in-patients-with-congenital/)
- [Biology of arteriovenous fistula failure](https://scholariq.org/papers/biology-of-arteriovenous-fistula-failure/)
- [Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy](https://scholariq.org/papers/genome-wide-association-analyses-define-pathogenic-signaling-pathways-and/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Central Venous Catheters and Hemodialysis](https://scholariq.org/topics/central-venous-catheters-and-hemodialysis/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)

## Researcher university

- [University of Calgary](https://scholariq.org/institutions/university-of-calgary/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.